New GHA Certification Helps Medical Tourism Facilitators Build Patient Trust
WEST PALM BEACH, Fla., Sept. 28, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) announces the launch of a new certification program for medical travel facilitators to assist in building patient trust. GHA's Medical Travel Facilitator Certification focuses on validating the capacity of medical tourism facilitator companies to provide appropriate services to clients that enhance safety and patient experience along...
Daiichi Sankyo joins Startup Creasphere’s Program Powered by Plug and Play
MUNICH, Sept. 28, 2022 /PRNewswire/ -- Startup Creasphere, the digital healthcare platform of Plug and Play, has announced its new partnership with Daiichi Sankyo. The partnership presents itself at the height of digital innovation in health, allowing for a unique opportunity for Daiichi Sankyo to join the Startup Creasphere ecosystem and the...
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency LEIDEN, The Netherlands, Sept. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam:...
Chugai Pharma Taiwan Awarded at the Asia Responsible Enterprise Awards 2022 for ‘Cycling for Charity’ under Social Empowerment Category
SINGAPORE, Sept. 28, 2022 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2022 is pleased to honor 72 exemplary award recipients for championing ESG to build a resilient world and a sustainable future for all. The AREA is the most prominent CSR recognition program across Asia initiated by the region's leading NGO, Enterprise Asia. The award recipients were selected...
KOTRA Call Indonesian Companies to Boost Economic Cooperation
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- On September 28, 2022, KOTRA, the Embassy of the Republic of Korea to Indonesia, and KADIN host the 'Indonesia-Korea Future New Industry Business Plaza 2022' at the Hotel Fairmont in Jakarta. The event includes a Future Industry Cooperation Forum between Indonesia and Korea, a Business Showcase, and one-on-one B2B meetings. More than...
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
-- After the pre-Phase III clinical trial meeting with Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) in June 2022, the pathway to the registration, including patient population, dose, treatment duration, etc. of ASC22 (Envafolimab) for functional cure of chronic hepatitis B (CHB) has been agreed -- The Phase IIb Expansion Cohort will enroll...
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a pivotal Phase III registration study that will bridge to Telix's global Phase III 'ZIRCON' trial of TLX250-CDx (89Zr-girentuximab), for the imaging...
First Patient in Australia Dosed with Illuccix® – Telix’s Approved Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose in Australia of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known as 68Ga-PSMA-11 injection. With Illuccix now available for delivery to all positron emission tomography (PET) imaging sites in Australia, Austin Health in...
EmeTerm Anti-Nausea Wristband Undergoes Clinical Study for Prevent of Postoperative Nausea and Vomiting
VANCOUVER, BC, Sept. 28, 2022 /PRNewswire/ -- Dr. YongHua Li conducted a clinical trial for EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., Vancouver, BC, Canada. The study spanned across three hospitals and was aimed to investigate EmeTerm's effectiveness in its transcutaneous electrical acupoint stimulation (TEAS) at PONV. The British Journal of Anaesthesia recently published an...
City-first Interactive Exhibition on Health Tech “Healthcare 3.0 Concept Hub” opens its doors in Central
Industry leaders and Start-Ups discuss the Future of Healthcare and Technology 3 Health Zones across 2 stories illustrating the future of Technology and Healthcare Please download high-resolution images here: HONG KONG, Sept. 27, 2022 /PRNewswire/ -- Since the pandemic, personal wellbeing has risen to our top priority. People are in constant pursuit of health under the new normal....
